Natera Stock News & Updates
[WKN: A14VPJ | Symbol: 45E]
Natera: How the Diagnostics Pioneer is Redefining the Cancer Market with Cell-Free DNA
Natera has a proprietary cfDNA platform that enables non-invasive, highly accurate diagnostic tests...
Natera: Early Cancer Detection via DNA Blood Tests Becomes a Mass Market
Blood instead of biopsy: customized DNA blood tests for cancer, pregnancy, and transplants – with...
Natera - Attractive Treatment Numbers Drive Momentum!
Business drivers: Natera (NTRA) specializes in genetic testing for the detection of serious and life-threatening...
Analysts' Top 5 Price Targets of September 3, 2025
Adidas [DE000A1EWWW0] JPMorgan places the stock on the "Positive Catalyst Watch" - the price...
Natera Shows Relative Strength — Will the Breakout now Succeed?
Meanwhile, we are seeing more and more tradeable setups again, with many stocks showing signs of a double...
Analysts' Top 5 Price Targets of March 13, 2025
IREN [AU0000185993]: JPMorgan upgrades from Neutral to Overweight, but lowers the price target from $15...
- ‹
- 1
- ›